Additionally, among the patients with HOXD3 methylation, age stratification showed a trend of rising prevalence of this marker with age ( Fig. 2 b).
← all excerpts
Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsies.
1
—
—